INOVIQ Ltd (ASX:IIQ)

Revenue by Product

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2009	Jun 30, 2008	Jun 30, 2007	Jun 30, 2006	Jun 30, 2005	Jun 30, 2004	Jun 30, 2003	Jun 30, 2002
Human Telomerase Reverse Transcriptase	333.26K
Human Telomerase Reverse Transcriptase Growth	-8.25%
Molecular Nets	201.86K
Molecular Nets Growth	477.02%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2009	Jun 30, 2008	Jun 30, 2007	Jun 30, 2006	Jun 30, 2005	Jun 30, 2004	Jun 30, 2003	Jun 30, 2002
South Korea	371.38K
South Korea Growth	54.31%
United States	163.74K
United States Growth	3.95%